Bluesight
PrivateLast Round
Growth Equity
Jul 17, 2023
Est. Valuation
$56.2M
Total Funding Raised
$37.5M
Momentum
Top 25%
of companies Caplight tracks
Company Overview
Bluesight is a healthcare technology company that provides an AI-powered medication intelligence and inventory management platform for hospitals and pharmacies.
Sector
Healthcare & Life Sciences
Verticals
Vertical SaaS, Healthcare Analytics, Pharma Supply Chain, Compliance & Risk
Business Model
B2B
Customer Profile
Subscription SaaS, Services & Consulting
AI Layer
Application
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Bluesight Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
Bluesight Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Growth Equity | Jul 17, 2023 | ||||
| Series C | Jun 20, 2016 | ||||
| Series B | Jan 12, 2015 | ||||
| Series A | Jul 16, 2013 | ||||
| Seed | Oct 1, 2012 |
Key People
Founding team and executive leadership
Bluesight Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Rock Health | Series A, Seed |
| New Leaf Venture Partners | Growth Equity, Series C, Series B, Series A |
| Monroe Capital | Growth Equity |
| Kaiser Permanente Ventures | Series C, Series B |
| Baxter Ventures | Series C |
| Black Granite Capital | Series C |
| Easton-Hunt Capital Partners, L.P. | Series A, Series C, Series B |
Market signals
Structured signals derived from secondary market and firmographic data.
- Mar 3, 2026
Integrating GraphiteRx data, including Mark Cuban Cost Plus Drugs, into CostCheck and ShortageCheck.
- Feb 12, 2026
PrivacyPro solution named Best-in-KLAS six times for patient privacy monitoring.
Bluesight Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about Bluesight's valuation, stock price, and market status.